Baxter (NYSE: BAX) reported Q3 EPS of $0.82, in-line with the analyst estimate of $0.82. Revenue for the quarter came in at $3.8 billion versus the consensus estimate of $3.77 billion.

GUIDANCE:

Baxter sees FY2022 EPS of $3.53-$3.60, versus the consensus of $3.62.

For earnings history and earnings-related data on Baxter (BAX) click here.